Mumbai, Mar 12: Institute of Clinical Research (India), (ICRI), in sponsorship with Indian Council for Medical Research (ICMR), will hold a two-day international conference on ''Global trends in Clinical Research: India 2008'' here from March 14.
The conference will serve as an international and neutral forum to address current solid scientific research in India pertaining to global development of drugs and biologics. Besides discussing the global trends in clinical research, the conference will focus on the real-world issues facing Clinical Research in India and look to develop a consensus on how India should move forward to ensure efficient, accurate, auditable and ethical Clinical Research data.
Leaders and experts from the pharmaceutical, academia and regulatory agencies will converge to discuss drug discovery and global clinical research.
All leading pharmaceutical companies like Ranbaxy, Quintiles, Dr Reddy's, Panacea Biotec, Fortis, Merck, Novo Nordisk and Unichem will participate in the conference.
Speaking to reporters here, ICRI Dean &Director General Dr S K Gupta said ''It will be a wonderful opportunity to interact with the learned scholars and professionals from the field of Clinical Research from around the world. This conference will act as a facilitating forum for participants to gain an insight into the active global issues impacting upon drug development in India. It will also provide possible solutions to current challenges faced by those undertaking Clinical Research in India.''
According to an ICRI study, the Clinical research industry is growing at an unparalleled rate. It has opened new vistas of employment for a large number of trained professionals. The clinical trials market worldwide is worth over USD 52 billion and the industry has employed an estimated 21,00,000 people in the US and over 70,000 in the UK, and they form one third of the total Research&Development staff. There are more than 2,50,000 positions vacant globally and annual salaries from USD 40,000 to USD 1,00,000 indicating that it is a well-paid career.
By 2010, according to McKinsey Report estimates, the volume of clinical research business in India is expected to be around USD 1000 million. ICRI views that this would translate into the opening up of 50,000 new career opportunities for life sciences and medical graduates in India.